Most Squamous Cell Carcinomas are Found in the Head and Neck Region.

Published Date: 27 Apr 2023

According to recent data on Medicare beneficiaries in the US, squamous cell carcinomas are more frequently found in the head and neck region of the body than in other places.

Read Full News

Latest News

When Self-Reflection Becomes a Physician’s Enemy

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Knowledge Areas: Transforming Hospital Care

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Extensive Screen Time Tied to CV Risk

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

The Clinical Dilemma of Withholding Futile Treatment

When the ‘default’ is aggressive care, how do clinicians handle nonbeneficial treatment?

Long-Term Data Support Early SAVR in Severe Aortic Stenosis

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic stenosis, according to long-term data from the RECOVERY trial.

Novel Wearable Detects Aortic Stenosis

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

Medical training makes self-examination a core virtue. But for many physicians, a habit meant to promote growth can quietly curdle into something damaging.

Vall d’Hebron reorganized care into Knowledge Areas; the Heart Area pilot cut length of stay by 18%, 30-day readmissions by 12%, and in-hospital mortality by 48% — early but promising.

Screen time is identified as an independent cardiovascular risk factor in an observational study of young adults living in Pakistan.

When the ‘default’ is aggressive care, how do clinicians handle nonbeneficial treatment?

At 10 years, early surgery continues to have a mortality benefit when compared with conservative care for asymptomatic aortic stenosis, according to long-term data from the RECOVERY trial.

A chest-worn biosensor that features several measurement signals in one device reliably identifies the presence and severity of aortic stenosis.

News All Time

Inflammation May Explain Link Between Belly Fat, HF

Excess abdominal fat — not overall body weight — may drive heart failure risk, with systemic inflammation being partially to blame.

Arterial Stiffness Changes Linked to Developing Dementia

Pulse wave velocity, calculated from age and blood pressure changes, was associated with significant dementia risk in a post hoc SPRINT analysis.

In High-BP Patients, Lifestyle Tied to Cardiometabolic Risk

Maintaining a healthy lifestyle was associated with a lower risk for major cardiometabolic diseases, regardless of antihypertensive medication use.

Triple Agonist Retatrutide Reduces A1c, Weight in T2D

Eli Lilly and Company report top-line phase 3 clinical trial results for its investigational GLP-1, GIP, and glucagon agonist in people with type 2 diabetes.

Tool Spots Heart Failure Risk Missed in Patients With ASCVD

A risk model predicts the risk for heart failure in patients with atherosclerotic cardiovascular disease and flags a notable proportion classified as low risk by other risk tools.

Are Nursing Homes Misprescribing Antipsychotics?

The HHS Inspector General claims that some nursing homes are inappropriately diagnosing residents with schizophrenia and prescribing antipsychotics without proper oversight.

CAC Still Predicts Heart Risk When Lp(a) Is High

An observational study shows the two factors to be independent predictors of atherosclerotic cardiovascular disease.

Is ‘Good’ Cholesterol Really Good? HDL Role Evolving

Both low and extremely high HDL cholesterol levels may increase cardiovascular risk.

Light Activity May Reduce HBP Risk in Pregnancy

No need for strenuous exercise: Consistent, daily light activity can reduce hypertension risk in pregnant women by 30%.

High Blood Pressure Is Risky, Even for Young Adults

Young adults with systolic blood pressure that is 10 points higher than that of their peers have a 27% greater risk for heart disease and a 22% greater risk for kidney disease after age 40.

Premature Menopause Linked With Greater Risk for CHD

Menopause before age 40 is correlated with a much greater risk for coronary heart disease, and therefore cardiologists should consider earlier preventive measures for this population.

HIV Status Affects Pregnancy-Related Cardiac Changes

Pregnancy history is associated with significant differences in cardiac structure and function, which vary by HIV status.

Match Day 2026: Is Family Medicine Half-Full or Half-Empty?

As medical students learn where they’ll spend their residencies, it’s clear they’re gravitating toward programs in higher-paying fields or those offering more work-life balance.

Women With Metabolic Risks More Prone to Liver Fibrosis

Women with certain cardiometabolic risk factors face a disproportionately greater increase in the odds of clinically significant liver fibrosis than men.

CSP vs BiV Pacing Trials Show Inconsistent Results

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

PREVENT Score Alters Hypertension Treatment Over 65

A new analysis shows the 2025 hypertension guideline’s risk-based framework spares a small subgroup from immediate treatment.

Recommended News For You

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Breast cancer-related fatigue: The benefits of adapted physical activity

After two years, a significant left nasal obstruction was finally diagnosed.

Is Laughter Good for Blood Glucose Control?

Review looks at potential treatment targets in the tumor microenvironment.

AMA President-Elect Confronts a New Challenge: A Brain Tumor

Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries

Recommended Articles For You

Therapeutic Innovations Through Germline Predisposition in Acute Leukemias and Myeloid Neoplasms 

Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment 

The Potential of Amifostine in Cancer Treatment: A Revolutionary Breakthrough 

Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Early Results for Anorexia Nervosa with Psilocybin.

2.

Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma

3.

Two medications might work better for breast cancers that are resistant to one.

4.

The most precise research tools for the deadliest blood cancer have been developed.

5.

Error on the MGUS-Autoimmune Disease Association.

1.

Immunotherapy Breakthroughs: Transforming Cancer Care Across All Oncology Fields

2.

Uncovering the Reality of Colon Cancer: A Look at Real Images

3.

Revolutionizing Lung Transplantation: The Promise of Donor-Specific Blood Transfusion

4.

Precision Oncology: Tailoring Cancer Treatment for the Individual

5.

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part III

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot